Amyotrophic Lateral Sclerosis Current Events | Amyotrophic Lateral Sclerosis News | 9
|
| Page
9 of
15 |
296 Results |
|
|
|
Sort By:
Page Views | Date |
Brain protein central to both Parkinson's, drug addiction identified
Scientists have identified a protein that appears not only to be central to the process that causes Parkinson's disease but could also play a role in muting the high from methamphetamine and other addictive drugs. view more (2009-05-05)
Bold Three-Stage Brain Operation for Intractable Seizures Appears Promising
Sadly, none of the treatments for epilepsy-anti-seizure medications, a procedure called vagus nerve stimulation, a special diet -could quell the electrical storms in the young boy's brain. view more (2006-05-08)
Discoveries should aid research into cause of ALS
Two teams of researchers at Northwestern University have found a novel pathological hallmark of the neurodegenerative disease amyotrophic lateral sclerosis (ALS) at the molecular level. view more (2006-04-26)
Boosting its infectivity turns benign virus into good gene therapy carrier for cystic fibrosis
Researchers from the University of California, Berkeley, and the University of Iowa have turned a relatively benign virus into a highly infectious form that is ideal as a carrier for gene therapy. view more (2009-02-17)
Mutation in brain cells of descendants of Abraham Lincoln suggest he suffered from movement disorder
Researchers at Johns Hopkins and the University of Minnesota have discovered a gene mutation in the descendants of Abraham Lincoln's grandparents that suggests the Civil War president himself might have also suffered from a disease that destroys nerve cells in the cerebellum- the part of the brain that controls movement. view more (2006-02-03)
Research set to enhance understanding of MS and stroke causes
A team of researchers from Sheffield's two universities is to investigate the role played by proteolytic enzymes (enzymes that break down proteins) in the development of multiple sclerosis (MS) and stroke. Understanding the role of these enzymes could be vital in advancing knowledge of how the conditions are caused, and finding ways to combat... view more... (2002-08-20)
Fewer injection site reactions in patients using Avonex
Data from an observational phase IV study of 499 patients entitled The Swiss MS Skin Project show that multiple sclerosis (MS) patients taking AVONEX (interferon beta-1a IM) reported significantly fewer injection site reactions (ISRs) compared to patients on Betaferon® (interferon beta-1b), Copaxone® (glatiramer Acetate) or Rebif ®... view more... (2009-09-11)
The Lancet Neurology November Issue Press Release
NO SEX PLEASE, WE`RE BRITISH (NEUROLOGISTS) It is well known in media circles that including the word "sex" in a headline is a sure-fire way of attracting the attention of potential readers. It is understandable, therefore, why a paper published in the Journal of Neurology, Neurosurgery, and Psychiatry (JNNP) entitled "Is multiple... view more... (2002-10-16)
Promising results in the battle against incurable ALS muscle disease
Leuven - ALS is an incurable, paralyzing neurodegenerative disorder that strikes 5 persons in every 100,000. The disease commonly affects healthy people in the most active period of their lives - without warning or previous family history. Researchers from VIB (the Flanders Interuniversity Institute for Biotechnology), under the direction of Prof.... view more... (2004-11-29)
UCLA, Italian chemists move closer to solving Lou Gehrig's disease mystery
Chemists from UCLA and the University of Florence in Italy may have solved an important mystery about a protein that plays a key role in a particular form of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, a progressive, fatal neurodegenerative disorder that strikes without warning. view more (2007-06-28)
New hope for multiple sclerosis sufferers
A drug which was developed in Cambridge and initially designed to treat a form of leukaemia has also proven effective against combating the debilitating neurological disease multiple sclerosis (MS). view more (2008-10-23)
Mount Sinai launches combination therapy trial to treat Relapsing-Remitting Multiple Sclerosis
Mount Sinai School of Medicine is the Clinical Coordinating Center for the first study to assess the effectiveness of combining two FDA approved medications as initial treatment for people with Relapsing Remitting Multiple Sclerosis view more (2006-04-12)
Adding steroid drug to MS treatment may reduce disease activity
Using a steroid drug for multiple sclerosis (MS) in addition to an MS drug may reduce the amount of disease activity more than using the MS drug alone. view more (2009-04-30)
The key of epilepsy can be in LGI1/Epitempina gene
Researchers of the Hospital of San Sebastian and the Biomedicine Institute of Valencia have discovered the genetic basis of hereditary epilepsy. The work leaded by the researchers Adolfo Lopez de Munain and Jordi Perez Tur has analysed the effect of the gene called LGI1/Epitempina. Temporal lateral epilepsy is the type of epilepsy that affects the... view more... (2002-05-07)
Early treatment favored for multiple sclerosis
An editorial accompanying a published debate on the pros and cons of starting treatment early in the course of multiple sclerosis comes down in favor of early treatment for this potentially devastating disease. view more (2006-05-24)
Neurons grown from embryonic stem cells restore function in paralyzed rats
For the first time, researchers have enticed transplants of embryonic stem cell-derived motor neurons in the spinal cord to connect with muscles and partially restore function in paralyzed animals. view more (2006-06-21)
New clue into how brain stem cells develop into cells which repair damaged tissue
The joint research, funded by the National Multiple Sclerosis Society and the UK MS Society as well as the National Institutes of Health and Howard Hughes Medical Institute, was conducted by scientists at the University of California San Francisco (UCSF) and University of Cambridge and was published today (01 July) in the journal Genes and... view more... (2009-07-02)
Glucosamine-like supplement inhibits multiple sclerosis, type 1 diabetes
A glucosamine-like dietary supplement has been found to suppress the damaging autoimmune response seen in multiple sclerosis and type 1 diabetes mellitus, according to University of California, Irvine health sciences researchers. view more (2007-05-15)
Tracking down the causes of multiple sclerosis
Over 100,000 people suffer from multiple sclerosis in Germany alone. Despite intensive research, the factors that trigger the disease and influence its progress remain unclear. view more (2009-06-11)
First 10-year follow-up shows that treatment with AVONEX leads to long-term benefits in early multiple sclerosis patients
Biogen Idec (NASDAQ: BIIB) today announced data results from the CHAMPIONS (Controlled High-Risk AVONEX® (interferon beta-1a) Multiple Sclerosis (MS) Prevention Study In Ongoing Neurologic Surveillance) study, an open label follow-up to CHAMPS (Controlled High Risk Subjects AVONEX MS Prevention Study). view more (2009-04-30)
|
|
| Page
9 of
15 |
296 Results |
|
|
|
Sort By:
Page Views | Date |
|
